Chan Heng Fai Ambrose - 02 Apr 2025 SCHEDULE 13D/A Report for IMPACT BIOMEDICAL INC. Common Stock

Filing Manager
Chan Heng Fai Ambrose
Reporting Manager
Heng Fai Ambrose Chan
Security
IMPACT BIOMEDICAL INC. Common Stock
Shares outstanding
12,122,586 shares
Disclosed Ownership
351,555 shares
Ownership
2.9%
Form type
SCHEDULE 13D/A
Filing time
04 Apr 2025, 17:15:32 UTC
Date of event
02 Apr 2025
Previous filing
02 Apr 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Heng Fai Ambrose Chan 2.9% 351,555 0 351,555 /s/ Heng Fai Ambrose Chan Heng Fai Ambrose Chan, an Individual 0001261725
Alset Inc. 2.9% 351,555 0 351,555 /s/ Heng Fai Ambrose Chan Heng Fai Ambrose Chan, Chief Executive Officer, Alset Inc. 0001750106
Alset International Limited 2.9% 351,555 0 351,555 /s/ Heng Fai Ambrose Chan Heng Fai Ambrose Chan, Chief Executive Officer, Alset International Limited 0001660984
Global Biomedical Pte. Ltd. 0% 0 0 0 /s/ Heng Fai Ambrose Chan Heng Fai Ambrose Chan, Director, Global Biomedical Pte. Ltd. 0001823066